Lundbeck lands cornerstone drug via $2.6B Longboard Pharma acquisition

The latest stories trending on MedCity News.

Editor's Pick

Top Story Lundbeck's Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition Lundbeck says Longboard Pharmaceuticals' drug, bexicaserin, has potential applications in a range of rare epilepsies. Last month, the biotech began a Phase 3 clinical trial testing the drug in Dravet syndrome. Sponsored Battle of the Budget: Employers vs. Rising Healthcare Costs Presented by Personify Health Join our webinar on October 24th at 1pm ET and hear from the panel as they discuss how employers are tackling the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being.

Featured News

Suki Secures $70M To Expand AI Offerings Suki's $70 million Series D financing round was led by Hedosophia and included participation from Venrock, March Capital, Flare Capital, Breyer Capital and inHealth Ventures. Community Pharmacies Fill Critical Healthcare Gaps in Rural Areas — Here's How We Can Empower and Support Them We need to equip pharmacists with technology that can help them to make impactful clinical interventions in the pharmacy and reimburse them for these services, which would help to address the provider shortage. Precision Psychiatry is Possible — Especially if We Use Evidence-based Neural Measures to Drive Better Mental Health Treatment and Outcomes By moving beyond subjective and heterogeneous criteria and embracing objective brain function measures, the field of psychiatry can achieve greater precision and efficacy in addressing complex disorders.

Resources

MedCity FemFwd: Addressing the Maternal Health Crisis with Dr. Bayo Curry-Winchell In this episode, we're joined by Dr. Bayo Curry-Winchell, founder of Beyond Clinical Walls and medical director of urgent care clinics at Saint Mary's Regional Medical Center. She discusses the role unconscious bias plays in maternal health disparities and ways the healthcare industry can address the maternal health crisis. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe